Earnings Call · Q1 FY2024·2024-05-02

Q1 24EPS +13.89%·Rev n/aQ4 23EPS +37.50%·Rev n/aQ3 23EPS -28.57%·Rev n/aQ2 23EPS +9.46%·Rev n/a⚠ consensus missing

Kymera Therapeutics, Inc. KYMR

Justine Koenigsberg — Investor Relations

Nello Mainolfi — President and CEO

Jared Gollob — Chief Medical Officer

Bruce Jacobs — Chief Financial Officer

+0.2%1d on move date−0.8% vs SPY3d+5.7%5d+6.2%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more KYMR calls or request research access.

More KYMR calls Browse calls Request research access